Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Ann Thorac Surg. 2017 Jan 25;104(1):98–105. doi: 10.1016/j.athoracsur.2016.10.021

TABLE 4.

GEE Regression models of postoperative outcomes in Matched Cohort

Univariable analysis All (n=1,351) Preoperative RAS inhibitor use Group comparison p-Values
No RASi (n=579) ARBs (n=193) ACEi (n=579) ARBs vs ACEi vs No RASi ARBs Vs No RASi ACEi Vs No RASi ARBs Vs ACEi
Major Perioperative Adverse Events (composite) 524 (38.8%) 219 (37.8%) 70 (36.3%) 235 (40.6%) 0.452 0.685 0.319 0.276
Postoperative inotrope use 806 (59.7%) 340 (58.7%) 125 (64.8%) 341 (58.9%) 0.271 0.124 0.952 0.155

Values represent n (%)

ARB = angiotensin receptor blockers;

ACEi = angiotensin receptor blockers;

RASi = renin angiotensin system inhibitors